68 related articles for article (PubMed ID: 8372566)
1. The role of -SH groups in the resistance of E. coli cells to cis-diamminedichloroplatinum(II) (cis-DDP).
Zastawny TH; Oliński R
Acta Biochim Pol; 1993; 40(1):48-50. PubMed ID: 8372566
[No Abstract] [Full Text] [Related]
2. [Molecular and cellular aspects of cis-diamminedichloroplatinum (II) interactions with DNA].
Zastawny TH; Oliński R
Postepy Hig Med Dosw; 1993; 47(2):103-23. PubMed ID: 8415320
[TBL] [Abstract][Full Text] [Related]
3. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
4. [ Effect of gamma radiation, cis-diamminedichloroplatinum and its derivates on the Escherichia coli cell survival and potentiality for adaptive response].
Zhestianikov VD; Janovska E; Savel'eva GE; Brabec V
Tsitologiia; 2001; 43(11):1067-74. PubMed ID: 11840783
[TBL] [Abstract][Full Text] [Related]
5. Gene expression caused by alkylating agents and cis-diamminedichloroplatinum(II) in Escherichia coli.
Fram RJ; Crockett J; Volkert MR
Cancer Res; 1988 Sep; 48(17):4823-6. PubMed ID: 3044578
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of cis-DDP and pyridoxal effect on isolated DNA during simultaneous application.
Rauko P; Novotný L; Balázová E
Neoplasma; 1993; 40(5):283-8. PubMed ID: 8272156
[TBL] [Abstract][Full Text] [Related]
7. [Use of Escherichia coli recF mutant strains for analyzing the genotoxicity of complex platinum compounds].
Ptitsyn LR; Riazanova LA; Ivanov VB
Genetika; 1997 Jul; 33(7):1020-4. PubMed ID: 9378282
[TBL] [Abstract][Full Text] [Related]
8. Effect of intracellular chloride on the cellular pharmacodynamics of cis-diamminedichloroplatinum(II).
Jennerwein M; Andrews PA
Drug Metab Dispos; 1995 Feb; 23(2):178-84. PubMed ID: 7736908
[TBL] [Abstract][Full Text] [Related]
9. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
Lippert B
Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
[TBL] [Abstract][Full Text] [Related]
10. Influence of temperature on platinum binding to DNA, cell killing, and mutation induction in Escherichia coli K-12 cells treated with cis-diamminedichloroplatinum(II).
Brouwer J; Fichtinger-Schepman AM; van de Putte P; Reedijk J
Cancer Res; 1982 Jun; 42(6):2416-9. PubMed ID: 7042085
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
Zhai X; Beckmann H; Jantzen HM; Essigmann JM
Biochemistry; 1998 Nov; 37(46):16307-15. PubMed ID: 9819223
[TBL] [Abstract][Full Text] [Related]
12. DNA adducts of cis-diamminedichloroplatinum(II) and its trans isomer inhibit RNA polymerase II differentially in vivo.
Mello JA; Lippard SJ; Essigmann JM
Biochemistry; 1995 Nov; 34(45):14783-91. PubMed ID: 7578087
[TBL] [Abstract][Full Text] [Related]
13. Further characterization of an E. coli strain resistant to the toxic and mutagenic action of cis-diamminedichloroplatinum(II).
Villani G; Lherisson C; Defais M; Johnson NP
Mutat Res; 1987 Jan; 183(1):21-9. PubMed ID: 3540652
[TBL] [Abstract][Full Text] [Related]
14. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair.
Lin X; Trang J; Okuda T; Howell SB
Clin Cancer Res; 2006 Jan; 12(2):563-8. PubMed ID: 16428501
[TBL] [Abstract][Full Text] [Related]
15. Repair of plasmid DNA damaged in vitro with cis- or trans-diamminedichloroplatinum(II) in Escherichia coli.
Popoff SC; Beck DJ; Rupp WD
Mutat Res; 1987 Mar; 183(2):129-37. PubMed ID: 3547106
[TBL] [Abstract][Full Text] [Related]
16. DNA-platinum-DNA cross-links formation induced by cis and trans-diamminedichloroplatinum in isolated leukocyte nuclei.
Walter Z; Spychała M
Acta Biochim Pol; 1992; 39(1):45-8. PubMed ID: 1441834
[No Abstract] [Full Text] [Related]
17. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
[TBL] [Abstract][Full Text] [Related]
18. Resistance to cisplatin in an E. coli B/r NalR mutant.
Bouayadi K; Villani G; Salles B
Mutat Res; 1993 Jun; 294(1):77-87. PubMed ID: 7683761
[TBL] [Abstract][Full Text] [Related]
19. Escherichia coli RecA promotes strand invasion with cisplatin-damaged DNA.
Nimonkar AV; Le Gac NT; Villani G; Boehmer PE
Biochimie; 2006 May; 88(5):535-42. PubMed ID: 16376475
[TBL] [Abstract][Full Text] [Related]
20. Recognition and repair of DNA-cisplatin adducts.
Woźniak K; Błasiak J
Acta Biochim Pol; 2002; 49(3):583-96. PubMed ID: 12422229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
